Viridian Therapeutics (NASDAQ:VRDN) Posts Quarterly Earnings Results, Beats Estimates By $0.21 EPS
Viridian Therapeutics (NASDAQ:VRDN – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.81) earnings per share for the quarter, beating the consensus estimate of ($1.02) by $0.21, FiscalAI reports. The firm had revenue of $25.75 million during the quarter, compared to the consensus estimate of $4.72 million. Viridian Therapeutics had a […]
5 Nov 07:26 · The Cerbat Gem